Objectives/Hypothesis: In vitro modeling of cell-matrix interactions that occur during human vocal fold scarring is uncommon, as primary human vocal fold scar fibroblast cell lines are difficult to acquire. The purpose of this study was to characterize morphologic features, growth kinetics, contractile properties, a-smooth muscle actin (a-SMA) protein expression and gene expression profile of human vocal fold fibroblasts derived from scar (sVFF) relative to normal vocal fold fibroblasts (nVFF).
INTRODUCTION
Vocal fold scarring can result from laryngeal surgery, radiation therapy, vocal fold trauma, and idiopathic causes. It commonly involves a physical disruption of the vocal fold edge, impaired glottic closure, and disordered lamina propria extracellular matrix (ECM) translating to loss of tissue viscoelasticity, decreased vibratory potential, and dysphonia. [1] [2] [3] Treatment modalities to prevent scar formation and/or to minimize subsequent detrimental effects have yet to be optimized 2, 4 and have been ascribed to poor understanding of the pathologic processes involved in the ECM of the vocal fold lamina propria.
The ECM is composed of collagen, elastin, hyaluronic acid, fibromodulin, decorin, and versican among other proteins. Vocal fold fibroblasts (VFF) produce a large proportion of the ECM and are key players in supporting the vocal fold lamina propria in health and disease. 5 Previous studies have shown that early recruitment of fibroblasts to the site of injury in the vocal fold is key to the wound-healing process. 6, 7 Further, fibroblasts involved in the wound-healing process in other parts of the body have been shown to undergo activation and manifest a phenotypic transition expressing asmooth muscle actin (a-SMA) transiently. 8 These modified fibroblasts, called myofibroblasts, have been documented to be involved in wound healing and contracture as well as with the formation of a collagen-rich scar. Little is known regarding how human VFF from injured or scarred tissue behave, as to date these have been unavailable for study. Although VFF are used extensively in in vitro research of the vocal folds, the majority of these have been derived from previously normal human or animal vocal fold tissue. 9, 10 In vivo canine, ferret, rat, mouse, porcine, and rabbit models have all been utilized to investigate different facets of the injury and/or wound-healing process in vocal fold mucosa. 11, 12 Although these studies have aided in determining pathways of scar formation and quantification of changes in the ECM, the next step would be to validate these findings with human tissue.
The objective of this study was to characterize the morphologic features, growth kinetics, contractile properties, a-SMA protein expression, and gene expression profile of human vocal fold fibroblasts derived from scar (sVFF) relative to normal vocal fold fibroblasts (nVFF). Based on findings from previous studies, it was hypothesized that sVFF would exhibit increased contraction, greater a-SMA expression, and greater proliferative rates than nVFF. With regard to ECM analysis, we hypothesized that there would be an overexpression of collagens I and III, as well as transforming growth factor-b (TGF-b), as these have been implicated in deposition of scar tissue and fibrosis.
MATERIALS AND METHODS

Fibroblast Isolation and Culture
Vocal folds of a 56-year-old female undergoing laryngofissure with bilateral mucosal grafts to replace severely scarred vocal folds were used for this study. Diagnosis for vocal fold scarring was made by the attending laryngologist after a full examination, which included videostroboscopy and high-speed imaging. Further, images were reviewed by five blinded clinicians who each have over seven years experience in voice. Descriptions of vibratory function included severe stiffness, lack of a discernible mucosal wave, and abnormal fibrotic tissue representing vocal fold scarring. The donor's prior laryngeal surgical history included multiple extensive biopsies of both vocal folds, with pathology revealing hyperkeratosis, parakeratosis, and chronic inflammation. Vocal fold samples were received immediately after excision and were placed in phosphate-buffered saline (PBS) for transport. The University of Wisconsin Madison Health Sciences Institutional Review Board approved the protocol for tissue procurement, and informed consent was received from the donor.
Normal vocal folds obtained from a 59-year-old female were also used in this study. Larynx and vocal folds were normal, with no evidence of disease, and were received immediately following excision. These primary fibroblasts have previously been characterized elsewhere. 10, 13 For primary cell culture, true vocal fold tissue was cut into small pieces and suspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 0.01 mg/mL streptomycin sulfate, and 1Â NEAA (all from Sigma, St. Louis, MO). Cells were grown on uncoated plastic tissue culture dishes (Focal) at 37 C in 5% CO 2 -humidified atmosphere. After 17 days, the adherent confluent sVFF were trypsinized and passaged. Cell culture conditions for nVFF were the same as for sVFF as described in Chen and Thibeault. 10 
Morphology
Passage 4, 5, and 6 nVFF and sVFF were each seeded on a 10-cm culture dish (BD Biosciences, Durham, NC) at a density of 300,000 in DMEM with 10% FBS, 1% penicillin/ streptomycin, and 1% nonessential amino acids (Sigma). Cells were allowed to reach 60% confluence, at which point photos were taken daily for 5 days via the Olympus CKX41 inverted light microscope (Olympus, Tokyo, Japan) at a magnification of 40Â. Photos of the cells were printed, and blinded assessments were then made to identify whether the photos belonged to nVFF or sVFF as well as passage identity by two raters.
Growth Characterization
Passage 5 cells were seeded at a density of 1.5 Â 10 4 cells per well each in a 24-well plate. The growth curves of the two cell lines, nVFF and sVFF, were determined by cell counts of parallel quadruplicate wells on a daily basis for 6 days. Analysis of variance (ANOVA) was performed between days 1 to 6 using Fisher protected least significant difference for post hoc analysis, and statistical significance was defined by P < .05.
Western Blot
nVFF and sVFF at passages 4, 5, and 6 were seeded into nine sterile uncoated 10-mm plates (three for each passage) and allowed to grow until they reached 90% confluence. Cells were then washed with PBS, and total cell protein was extracted using the M-PER protein extraction kit (Pierce, Rockford, IL) according to the manufacturer's instructions. Total protein was quantified using bicinchoninic acid assay method (Pierce). Protein aliquots were stored at À80 C. For each protein sample, 1.5 lg of total protein was characterized electrophoretically on NuPAGE 10% Bis-Tris gels (Invitrogen, Carlsbad, CA) under reducing conditions using NuPage 3-(n-morpholino)propanesulfonic acid (MOPS)-sodium dodecyl sulfate (SDS) buffer. Protein was transferred onto a polyviylidene fluoride membrane using an XCELL Blot Module (Invitrogen). MagicMark XP Western protein standard (Invitrogen) was used to validate bands in the range of 20 to 220 kDa. Membranes were probed for a-SMA with an a-SMA antibody mouse clone 1A4 (Sigma) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using a mouse anti-GAPDH antibody (Sigma). Membranes were blocked overnight using blocking solution in 4 C and then incubated with a 1:1000 dilution of mouse monoclonal a-SMA antibody for 1 hour at room temperature and a 1:20,000 dilution of anti-GAPDH antibody. Bound antibodies were detected using the WesternBreeze anti-mouse chemiluminescent kit (Invitrogen). Chemiluminescent signal was captured using the LAS-4000 (GE Healthcare, Piscataway, NJ). Densities of the bands were measured using ImageJ (National Institutes of Health, Bethesda, MD). Differences between densities of a-SMA expression between cell lines were analyzed with ANOVA. Post hoc analysis was conducted using Fisher protected least significant difference tests. Statistical significance was defined by P .05.
Immunocytochemistry
Cells were studied using immunofluorescent staining with antibodies directed against a-SMA (Sigma). Passage 4 nVFF and sVFF were seeded in quadruplicate into sterile Permanox 4 chamber slides (Sigma) at a density of 1000 cells/well in DMEM-10% FBS and incubated until they reached 50% confluence. nVFF at 70% confluence, treated with TGF-b at a concentration of 10 ng/mL over 48 hours in serum-free media, served as a positive control. Cells were washed with PBS and then fixed in 4% paraformaldehyde for 10 minutes at room temperature. Cells were washed three times with 0.1% Triton X-100 (Sigma) in PBS for 5 minutes each. Serum blocking was conducted for 60 minutes using 5% normal goat serum in PBS. Primary antibody (mouse anti-a-SMA; Sigma) was diluted to the appropriate concentration in blocking solution (1:250), and cells were incubated with this antibody for 90 minutes. Cells were once again washed three times with the Triton/PBS solution for 5 minutes each. Species-specific secondary antibody (Alexa 488 labeled goat anti-mouse; Invitrogen) was diluted to the 1:200 in PBS and cells were incubated with secondary antibody for 60 minutes in a dark chamber. Slides were washed with 1% Triton X-100 in PBS at the end of secondary incubation and then were quickly rinsed with dH 2 O. Chambers and gaskets were carefully removed, and slides were mounted with Vector aqueous anti-fade fluorescent mounting medium with 4 0 ,6-diamidino-2-phenylindole. Images were captured using a Nikon Eclipse E600 Epi Flourescence inverted microscope (Nikon, Tokyo, Japan) at 200Â magnification and subsequently analyzed qualitatively for the presence of green fluorescence indicative of a-SMA by two raters who were naïve to the purpose of the study.
Collagen Gel Contraction Assay sVFF (p6) and nVFF (p5) were cultured in medium (10% FBS, 1% AA, 1% P/S) and trypsinized, counted, and 480,000 cells were seeded in wells each containing 1.5 mL collagen gel lattices (Cell Biolabs, San Diego, CA). After polymerization and a culture period of 2 days, the contraction assay was completed. Stressed matrices were released from the surrounding brim of the wells. Pictures of free-floating collagen gel lattices were taken at full optical zoom using the white light setting on a BioDoc-It imaging system (UVP, Upland, CA) immediately after release as well as 24 and 48 hours later. After blinding for cell type and time point, areas of collagen gel size were analyzed with ImageJ (National Institutes of Health) and normalized to areas of the well. Degree of contraction was evaluated by determining the area of the gel matrix at each time point. The assay was run in triplicate for each cell type, and a cell-free collagen matrix was used as a comparison control. Mean gel area was compared across each time point and group using an ANOVA and Fisher protected least significant difference tests with statistical significance assigned at P < .05.
Gene Expression by Quantitative Reverse-Transcriptase Polymerase Chain Reaction sVFF (p5) and nVFF (p5) were trypsinized, and total RNA was extracted according to a standard protocol (Invitrogen). RNA samples were assessed for purity by ultraviolet spectrophotometry; A260/A230 ratio was over 1.8, and A260/ A280 ratio was >2.0. Template cDNA prepared from total RNA of sVFF and nVFF was characterized in technical triplicates using the Human Extracellular Matrix and Adhesion Molecule PCR Array with the RT 2 SYBR Green/Fluorescein PCR master mix (SABiosciences, Frederick, MD) on the 7500 Fast RealTime PCR System (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Data generated from the arrays were analyzed by an Excel-based (Microsoft Corp., Redmond, WA) analysis template (SABiosciences). Gene expression was calculated from the number of cycles by using standard curves, and the results were normalized to three stable housekeeping genes (B2M, GAPDH, ACTB). Fold-change (2^[-Delta Delta Ct]) was calculated based on normalized gene expression (2^[-Delta Ct]) in the sVFF divided by the normalized gene expression (2^[-Delta Ct]) in the nVFF. P values were calculated based on a Student t test of the replicate 2( Delta Ct) values for each gene in the nVFF group and sVFF group. As we were examining multiple genes, we chose a more stringent P value for statistical significance of P < .01 to control for type I error.
RESULTS
Morphology and Growth Characterization
nVFF and sVFF were compared over passages 4 to 6 for morphology. Both cell lines demonstrated a typical spindle shape and did not deviate from this standard at any of the passages (Fig. 1) , nor did they differ from each other. No significant difference in growth rate was seen on days 1 and 2. nVFF were found to have faster proliferation rates than sVFF, with significantly different proliferative rates on days 3 to 6 (day 3: P ¼ .0138; days 4, 5, and 6: P < .0001) (Fig. 2) .
Western Blot Analysis and Immunocytochemistry
To explore differences in a-SMA expression in nVFF and sVFF, we conducted western blot and immunocytochemistry (ICC) analysis. Although both cell lines differentially expressed a-SMA, this difference was more apparent in western blot densitometric analyses, which indicated that sVFF had significantly greater expression at passages 4 and 5 compared to nVFF (P ¼ .006 and P ¼ .0015, respectively). There was no difference in a-SMA expression between sVFF and nVFF at passage 6 (P ¼ .8860) (Fig. 3) . Subjective assessment of ICC images (Fig. 4) showed sVFF (Fig. 4B) had stronger a-SMA staining in cytoplasmic myofilaments than nVFF (Fig. 4A) .
Fibroblast-Populated Collagen Lattice Contraction
Following release of the collagen lattice from the bottom of the wells, nVFF and sVFF each contracted within 24 hours. At 24 hours, collagen contracted 58% with sVFF, 59% with nVFF, and 14% for the unpopulated collagen matrix. There were no significant differences in collagen lattice contraction for sVFF relative to nVFF at any of the time points (P ¼ .70, P ¼ .79, P ¼ .58 for 0 hours, 24 hours, and 48 hours, respectively), although both were significantly different from control at 24 and 48 hours following release of the collagen matrix (P < .001) (Fig. 5) .
Gene Expression Analysis
Using a real-time polymerase chain reaction array, we investigated the differences in expression of 84 genes encoding proteins important in extracellular matrix homeostasis and cell adhesion. All genes were detected in both cell types; however, two genes within nVFF and one gene within sVFF showed relatively high average threshold cycles, meaning that their relative expression levels were low. For nVFF, ITGAM and SELE were minimally expressed, whereas for sVFF, NCAM1 was minimally expressed. Fifteen ECM and adhesion molecule genes were significantly differentially expressed Fig. 3 . Representative Western blots showing a-smooth muscle actin (a-SMA) expression and glyseraldehyde-3-phosphate dehydrogenase (GAPDH) for normal vocal fold fibroblasts and vocal fold fibroblasts derived from scar (sVFF) at passages 4, 5, and 6. Graphs contain corresponding densitometric analysis of a-SMA that was normalized to GAPDH for each passage. Significance in upregulation was observed at passages 4 and 5 for sVFF (P ¼ .0006 and P ¼ .0015, respectively). between sVFF and nVFF at P < .01 (Table I) . sVFF had downregulated expression of NCAM1 (À87.11-fold change), COL11A1 (À40.71-fold change), ITGB3 (À13.98-fold change), ITGA2 (À9.05-fold change), ITGA3 (À8.16-fold change), MMP10 (À6.57-fold change), CLEC3B (À6.35-fold change), PECAM1 (À5.64-fold change), ITGB4 (À3.37-fold change), TNC (À2.66-fold change), and TIMP1 (À2.46-fold change). The following genes were found to be upregulated in sVFF relative to nVFF: LAMA1 (65.52-fold change), THBS2 (13.19-fold change), MMP3 (11.62-fold change), and THBS1 (4.04-fold change).
DISCUSSION
Effective and long-term clinical strategies for managing vocal fold scarring have yet to be developed. Recent research has focused on the use of animal models to explore tissue engineering scaffolds and cellular-based therapies. Animal models are the current standard for exploring vocal fold scarring etiology and treatment, given the inherent barriers in procuring vocal fold tissue from humans. In this study, we were successful in deriving fibroblasts from chronically scarred human vocal folds and examined several phenotypic, genotypic, and protein expression properties of these cells relative to vocal fold fibroblasts derived from a normal human donor of similar age. We reported with one biological sample of sVFF that these cells grew slower than nVFF, although they displayed similar morphology and contractile properties. western blot and ICC analyses revealed elevated a-SMA in sVFF. Genotypically, we reported on 15 differentially expressed genes between sVFF and nVFF.
Morphological comparative assessments of nVFF and sVFF at passages 4, 5, and 6 did not show any distinguishable characteristics. These findings mirror similarities reported between normal lung fibroblasts and those derived from idiopathic pulmonary fibrosis (IPF).
14 In contrast, Kumai et al. 15 examined morphologic differences in nVFF and sVFF from ferrets and reported sVFF to be more elongated and to have fewer processes than nVFF. In that study, sVFF were isolated from vocal fold scar tissue that had been induced 2 weeks prior to dissection, and morphological analysis was based on passage 3 cells. The lack of differences in morphologic characteristics in the present study may result from the presumption that human scar tissue obtained for the present study represents a more chronic condition. Others have reported morphologic differences in keloid or hypertrophic scar versus normal dermal fibroblasts. 16, 17 One possible explanation of our disparate findings may be that we determined morphological differences based on blinded judgments of printed images from light microscopy, whereas other studies have reported on differences found in light and electron microscopy under potentially unblinded conditions.
Following tissue damage and the subsequent inflammatory reaction, activated fibroblasts begin to migrate, proliferate, and differentiate into subpopulations. Myofibroblasts, which express a-SMA, are considered a contractile activated fibroblast, and are mainly responsible for scar contraction and excessive ECM deposition. By ICC and western blot, sVFF showed greater expression of a-SMA compared with nVFF, indicating that a proportion of the sVFF we studied were phenotypically myofibroblasts. Although some nVFF displayed myofibroblast phenotype via expression of a-SMA, this has been shown to be a normal finding during cell cycle progression and differentiation of fibroblasts in culture. 18, 19 Similar investigations of IPF fibroblast phenotype, relative to fibroblasts isolated from normal lung tissue using confocal microscopy and flow cytometry, have revealed greater proportions of a-SMA-positive IPF fibroblasts compared to normal lung fibroblasts, suggesting that the majority of IPF fibroblasts were myofibroblasts. 14, 20 In a ferret model, Kumai et al. 21 measured a-SMA-positive nVFF and sVFF in monoculture by flow cytometry and immunohistochemistry and also reported significantly greater a-SMA expression in sVFF. Although it is generally believed that myofibroblasts undergo apoptosis after epithelialization occurs, it has been suggested that this mechanism fails to work in certain fibrotic diseases (e.g., liver cirrhosis) and in keloids or hypertrophic scars, leading to persistence of myofibroblasts and the expansion of the extracellular matrix. 22, 23 It is possible that a similar mechanism is responsible for vocal fold scarring in humans.
Results of a growth and proliferation assay demonstrated that sVFF grew significantly slower than nVFF. Our concurrent finding that sVFF may phenotypically be myofibroblasts supports this finding. Ramos et al. 20 observed a marked decrease of growth rate in fibroblasts derived from lung tissue of patients with IPF when compared with lung fibroblasts derived from normal subjects at passages 5 to 8. Based on the theory that myofibroblast differentiation in vitro results in reduced telomerase activity, they speculated that decreased expression of telomerase may have accounted for the reduced proliferative capacity of IPF-derived fibroblasts. We did not measure telomerase expression in the current study; however, this theory warrants further investigation. In contradiction, comparing nVFF and sVFF from ferrets, Kumai et al. 15 observed faster proliferation of sVFF relative to nVFF in monoculture conditions. Others have found no difference in growth kinetics between scar-derived and normal dermal fibroblasts under standard culture conditions in vitro. 24, 25 These discrepant findings likely reflect differences in methodologies employed for the various studies, including tissue origin, cell passage number, and growth medium. The capacity of fibroblasts to organize and contract collagen by tractional structuring is most important in early wound healing to facilitate rapid epithelialization. The fibroblast-collagen-matrix contraction model is a way to examine mechanisms that contribute to wound healing, as the mechanical forces generated by fibroblasts that lead to wound contraction can be large enough to cause considerable scarring. The contraction assay used in our study involved a 2-day period of mechanical loading, whereby isometric tension developed. Within this paradigm, cells have been found to form large extensions and stress fibers that collapse and disappear when matrices are released. 26 Upon release of the collagen matrices in our study, both nVFF-and sVFF-populated matrices contracted; however, there was no difference in contraction between the two cell types. A similar finding has been reported within the dermal literature with comparison of burn hypertrophic scar and normal skin fibroblasts. 27 Data from matrix metalloproteinase 3 (MMP3)-deficient mice have shown that MMP3 is critical for initiating wound contraction in the early stages of wound healing. 28 We found that MMP3 was significantly upregulated in sVFF, although this finding does not explain the absence of differential contraction seen between sVFF and nVFF. Boemi et al. 29 characterized differences between scar and dermal cultured fibroblasts at passages 3 to 8 and found more a-SMA within cytoplasmic stress fibers, reduced expression of the collagen integrin receptor a-2, and reduced collagen contraction in scar fibroblasts relative to dermal fibroblasts. They speculated that a decreased level of a-2 integrin, a collagen-binding cell surface receptor, was responsible for their finding of reduced lattice contraction in scar fibroblasts. We also found that the genes encoding several integrin subunits (ITGA2, ITGA3, ITGB3, and ITGB4) were underexpressed in sVFF, suggesting that cell-cell and cell-matrix interaction and communication may have been compromised in the in vivo scar environment. It has been shown that dermal fibroblasts during the early stages of wound-healing express mainly a-2 and a-5 subunits of integrins associated with an upregulation of the b-1 subunit. 30 In spite of genotypic differences in MMP3 and integrin subunit a-2, sVFF and nVFF demonstrated similar contractive properties, suggesting that there are other mechanisms responsible for this finding.
Matrix metalloproteinases are involved in the breakdown of ECM in tissue remodeling and disease processes. We determined that the gene encoding MMP3 was significantly upregulated for sVFF versus nVFF. MMP3, or stromelysin, degrades fibronectin, laminin, and collagens III, IV, IX, and X. Although normal dermal scars in vivo contain little message and subsequent protein for fibronectin, it has been reported that cultured fibroblasts derived from these scars have fibronectin messenger RNA and rates of biosynthesis in vitro similar to those of keloid fibroblasts. 31 In both cases, fibronectin biosynthesis is significantly greater than that found in normal dermal tissue, indicating that the fibronectin regulatory pathway in scar fibroblasts is likely influenced by the tissue environment. Overall, our finding of upregulation of MMP3 in sVFF is perplexing, as one would expect a downregulation given what has been reported in the literature; however, our contradictory results may be explained by culture conditions. In the dermal fibroblast literature, expression of MMP3 showed statistically significant decreases with increasing cell density, such that expression was lower in confluent compared with preconfluent cells and in postconfluent versus confluent cells. 32 Even though care was taken to ensure equivalent cell counts for RNA extraction and cDNA synthesis between cell types, cells were trypsinized at 80% to 90% confluence, representing a preconfluent state, which may have affected MMP3 expression. Future studies should consider confluence as a potentially relevant factor in differential gene expression, with care taken to ensure equal confluence across comparison cell types.
Several limitations in the present investigation related to both methodology and analysis warrant discussion. First, serial passaging and freeze-thaw cycles endured by both nVFF and sVFF may have impacted phenotype, as it has been demonstrated that vascular smooth muscle cells in culture show disassembly of actin stress fibers after passage 3 and a reduction in a-SMA protein expression after freezing-thawing. 33 Further, vocal fold fibroblasts have been found to undergo replicative senescence beyond passage 5. 34 This study evaluated cells at passages 4 to 6, leading to the possibility that there may have been significant differences in collagen contraction and even more robust differences in expression of a-SMA between nVFF and sVFF at earlier passages or had the cells not been frozen.
A major limitation of the present study is our lack of replicates as we were only able to compare one biological sample of sVFF to one biological sample of nVFF. Confirmation and replication of our results with additional biological samples is necessary. Just as there is variation among normal cell lines, it is unlikely that all vocal fold scars would exhibit the same in vitro behavior, particularly with differences in donor age, smoking history, reflux history and etiology of the scar. For instance, it is known that for normal fibroblasts, including nVFF, proliferation is inversely related to donor age. 10, 35 Other differences in nVFF have included decreases in relative expression of fibronectin, collagen I, collagen VI, procollagen I, and elastin, as well as shifts in morphology from a typical spindle shape to wider, shorter cells at earlier passages with increasing donor age. 10 Histologic analysis of the normal tissue and vocal fold scar used in this study may have revealed in vivo characteristics of these tissues, such as collagen composition and fiber alignment, potentially lending support to our in vitro findings. Given the qualitative ICC and western blot findings of elevated a-SMA in sVFF relative to nVFF, it would be beneficial to quantify these findings using flow cytometry to determine specific proportions of a-SMAexpressing myofiboblasts for both cell types. For this reason, further investigation comparing primary sVFF to myofibroblasts is also warranted.
Although the data described herein are interesting, the real value of performing such in vitro experiments is not to describe the basal phenotype, but rather to investigate mechanistic complexities underlying this phenotype, which cannot be assayed in vivo. Therefore, future studies will aim to examine the effects of various molecules on sVFF in vitro, including cytokines, chemokines, and growth factors, with the goal of expanding the scope of current human models of vocal fold scarring. Assessing cellular changes under vibratory conditions may help to illuminate genotypic and phenotypic responses associated with the types of mechanical forces present within the laryngeal microenvironment. This model may provide a better approximation of the in vivo environment from which these cells were isolated.
CONCLUSION
In comparing a single sample of fibroblasts derived from vocal fold scar to fibroblasts derived from normal tissue, this study provides the first data to suggest that human sVFF and nVFF display differences in proliferative capacity, a-SMA expression levels, and gene expression. Results also indicate no difference in morphology or contractile properties. Given visually significant differences in tissue phenotype observed with videostroboscopy, the inherent in vitro differences reported herein were not as pronounced as had been expected. In all likelihood, this relates to the complexities of the in vivo environment, such that in vitro models can be viewed as approximations of what actually occurs in the living organism. Additional biological replicates are necessary to further characterize the in vitro properties of human vocal fold scar; however, these preliminary data will inform future in vitro studies investigating the use of fibroblasts as a therapeutic target in the treatment of vocal fold scarring.
